Ilika plc Now granted eight of its Stereax® solid-state battery patent filings

Ilika Plc

Ilika plc (LON: IKA), a pioneer in solid-state battery technology, announced today that it has been granted eight of its Stereax® solid-state battery patent filings in five patent jurisdictions.

Over the past two years, Ilika has seen substantial progress in the prosecution of this aspect of its patent portfolio at the Patent Offices of China, Korea, Japan, USA and Europe. As a result, three of its patent families are significantly stronger, with eight related filings going to grant and notices of allowance being issued for a further four.

Ilika01 (Ika)

These patent filings protect the methods used to make Ilika’s thin-film solid-state Stereax® cells. The Stereax® roadmap commenced with miniature batteries designed to meet the demands of powering wireless devices and has been extended to include large format cells for automotive.

Ilika CEO Graeme Purdy said:

“Protecting Ilika’s know-how relating to solid-state batteries is key to our ability to grow our business. We take this very seriously and employ a Vice President of Intellectual Property, who is seconded to the Company from an international firm of patent lawyers to manage this process for us. This strategy is validated by the continued stream of granted patents reinforcing our position.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search